메뉴 건너뛰기
Oscotec Inc.
Translating science into medicine
로그인 유지
ID/PW 찾기
회원가입
로그인
회원가입
로그인
HOME
COMPANY
About Us
History
Members
Contact Us
PIPELINE
Pipeline Overview
Rheumatoid arthritis
Immune thrombocytopenia
Acute myeloid leukemia
Non-small cell lung cancer
Alzheimer's disease
NEWSROOM
Notice
Press Releases
Publications
IR Materials
Shareholder Notice
PRESS
주주님들께 드리는 글
2022.08.30
SCI Journal - SKI-G-8...
2022.02.16
FLT3/AXL Inhibitor (A...
2020.06.22
HOME
COMPANY
About Us
History
Members
Contact Us
PIPELINE
Pipeline Overview
Rheumatoid arthritis
Immune thrombocytopenia
Acute myeloid leukemia
Non-small cell lung cancer
Alzheimer's disease
NEWSROOM
Notice
Press Releases
Publications
IR Materials
Shareholder Notice
×
WELCOME
로그인 유지
ID/PW 찾기
×
LANGUAGE : 한국어
English
NEWSROOM
Notice
Press Releases
Publications
IR Materials
Notice
Press Releases
Publications
IR Materials
NEWSROOM
- Notice
- Press Releases
- Publications
- IR Materials
Home
NEWSROOM
Press Releases
T
기본글꼴
기본글꼴
✔
나눔고딕
✔
맑은고딕
✔
돋움
✔
✔
사이트를 뷰어로 보기
검색
Write
Title+내용
Title
내용
Comment
이름
닉네임
아이디
태그
검색
List
Zine
Gallery
"ASCO 2018: Genosco/Yuhan Announce Results from Phase 1/2 Study of Lazertinib (YH25448, GNS-1480), a 3rd-Generation EGFR-TKI, in Advanced NSCLC"
Date
2018-06-03
Media
Businesswire
Pipeline
Lazertinib
Read More
Board Pagination
Prev
1
2
3
Next
/ 3
GO
© k2s0o1d6e0s8i2g7n. ALL RIGHTS RESERVED.
서버에 요청 중입니다. 잠시만 기다려 주십시오...